Adoptive immunotherapy of human gastric cancer with ex vivo expanded T cells

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Archives of pharmacal research

• Publication date

  2010-11-30

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s12272-010-1111-7PMID 21116782
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Molecular basis of therapeutic approaches to gastric cancer

  2009cited by this paper
• In vivo trafficking and survival of cytokine-induced killer cells resulting in minimal GVHD with retention of antitumor activity.

  2008cited by this paper
• Prospective study of chemotherapy in combination with cytokine-induced killer cells in patients suffering from advanced non-small cell lung cancer.

  2008cited by this paper
• Multidisciplinary management of gastric and gastroesophageal cancers.

  2008cited by this paper
• VEGF-C and VEGF-A synergistically enhance lymph node metastasis of gastric cancer.

  2007cited by this paper
• Antitumor activity of cytokine-induced killer cells against human lung cancer.

  2007cited by this paper
• Adjuvant chemotherapy with epirubicin, leucovorin, 5-fluorouracil and etoposide regimen in resected gastric cancer patients: a randomized phase III trial by the Gruppo Oncologico Italia Meridionale (GOIM 9602 Study).

  2007cited by this paper
• Inhibition of human ovarian tumor growth by cytokine-induced killer cells

  2007cited by this paper
• Anti-tumor activity of ex vivo expanded cytokine-induced killer cells against human hepatocellular carcinoma.

  2007cited by this paper
• Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine.

  2007cited by this paper
• [Antitumor effects of cocultured dendritic cells and cytokine-induced killer cells on lung cancer in vitro and in vivo].

  2006cited by this paper
• Recognition of breast cancer cells by CD8+ cytotoxic T-cell clones specific for NY-BR-1.

  2006cited by this paper
• Generation of tumor-reactive effector lymphocytes using tumor RNA-introduced dendritic cells in gastric cancer patients.

  2006cited by this paper
• Synergistic Antitumor Effects of Immune Cell-Viral Biotherapy

  2006cited by this paper
• Treatment of advanced gastric cancer by chemotherapy combined with autologous cytokine-induced killer cells.

  2006cited by this paper
• Cytokine‐induced killer cells against autologous CLL: Direct cytotoxic effects and induction of immune accessory molecules by interferon‐γ

  2006cited by this paper
• Cell delivery system: a novel strategy to improve the efficacy of cancer immunotherapy by manipulation of immune cell trafficking and biodistribution.

  2005cited by this paper
• Studies on Inducing Apoptosis Effects and Mechanism of CIK Cells for MGC-803 Gastric Cancer Cell Lines

  2005cited by this paper
• Effective prevention of lethal acute graft-versus-host disease by combined immunosuppressive therapy with prodigiosin and cyclosporine A.

  2005cited by this paper
• Adjuvant therapy in gastric cancer.

  2005cited by this paper
• Transactivation of epidermal growth factor receptor is involved in leptin-induced activation of janus-activated kinase 2 and extracellular signal-regulated kinase 1/2 in human gastric cancer cells.

  2005cited by this paper
• Dendritic cells as vectors for immunotherapy of tumor and its application for gastric cancer therapy.

  2004cited by this paper
• Principles of surgical treatment for curable gastric cancer.

  2003cited by this paper
• Induction of T Lymphocytes Specific to Human Gastric Cancer Using HLA-A Matched Allogeneic Gastric Tumor Cells

  2003cited by this paper
• Expression of gastric cancer-associated MG7 antigen in gastric cancer, precancerous lesions and H. pylori -associated gastric diseases.

  2002cited by this paper
• Inducing Tumor Immunity through the Selective Engagement of Activating Fcγ Receptors on Dendritic Cells

  2002cited by this paper
• Prodigiosin blocks T cell activation by inhibiting interleukin-2Ralpha expression and delays progression of autoimmune diabetes and collagen-induced arthritis.

  2001cited by this paper
• Expansion of cytolytic CD8(+) natural killer T cells with limited capacity for graft-versus-host disease induction due to interferon gamma production.

  2001cited by this paper
• Prodigiosin Blocks T Cell Activation by Inhibiting Interleukin-2Rα Expression and Delays Progression of Autoimmune Diabetes and Collagen-Induced Arthritis

  2001cited by this paper
• Adoptive immunotherapy to lower postsurgical recurrence rates of hepatocellular carcinoma: a randomised trial.

  2000influential reference
• Induction of cytotoxic T-lymphocyte responses in vivo after vaccinations with peptide-pulsed dendritic cells.

  2000cited by this paper
• Identification of HER2/neu‐derived peptide epitopes recognized by gastric cancer‐specific cytotoxic T lymphocytes

  1998cited by this paper
• HLA class‐I‐restricted and tumor‐specific CTL in tumor‐infiltrating lymphocytes of patients with gastric cancer

  1997cited by this paper
• A novel population of expanded human CD3+CD56+ cells derived from T cells with potent in vivo antitumor activity in mice with severe combined immunodeficiency.

  1994influential reference
• The second British Stomach Cancer Group trial of adjuvant radiotherapy or chemotherapy in resectable gastric cancer: five-year follow-up.

  1994cited by this paper

• Inhibition of human gastric cancer growth by cytokine-induced killer cells plus chemotherapy with or without cadonilimab in a mouse xenograft tumor model

  2025cites this paper
• Classification based on tumor phenotypes enables the novel molecular characterization of esophagogastric junction cancer

  2025cites this paper
• A rapid ex vivo co-culture of memory-like NK and activated T cells enhances anti-tumor response in gastric cancer.

  2025cites this paper
• Research Progress of Immunotherapy for Gastric Cancer

  2023cites this paper
• Elevated linc00936 or silenced microRNA-425-3p inhibits immune escape of gastric cancer cells via elevation of ZC3H12A.

  2021cites this paper
• Novel Immunotherapeutic Approach in Gastric Cancer

  2020influential citation
• Immune Cells Combined With NLRP3 Inflammasome Inhibitor Exert Better Antitumor Effect on Pancreatic Ductal Adenocarcinoma

  2020cites this paper
• Immunotherapy of Gastric and Esophageal Cancers

  2020cites this paper
• Targeted therapy for upper gastrointestinal tract cancer: current and future prospects

  2020cites this paper
• The long-term efficacy of cytokine-induced killer cellular therapy for hepatocellular carcinoma: a meta-analysis.

  2019cites this paper
• Prognostic significance of tumor immune microenvironment and immunotherapy: Novel insights and future perspectives in gastric cancer

  2018cites this paper
• Multimodal Anti-tumor Approaches Combined with Immunotherapy to Overcome Tumor Resistance in Esophageal and Gastric Cancer

  2018cites this paper
• What’s New in Gastric Cancer: The Therapeutic Implications of Molecular Classifications and Future Perspectives

  2018cites this paper
• An abscopal effect in a case of concomitant treatment of locally and peritoneally recurrent gastric cancer using adoptive T‐cell immunotherapy and radiotherapy

  2017cites this paper
• Immunotherapeutic Strategies for Gastric Carcinoma: A Review of Preclinical and Clinical Recent Development

  2017cites this paper
• Cytokine-induced killer cells hunt individual cancer cells in droves in a mouse model

  2017cites this paper
• Synergistic effect of cytokine-induced killer cell with valproate inhibits growth of hepatocellular carcinoma cell in a mouse model

  2017cites this paper
• Immunotherapy for oesophagogastric cancer

  2016cites this paper
• Prognostic potential of an immune score based on the density of CD8+ T cells, CD20+ B cells, and CD33+/p-STAT1+ double-positive cells and HMGB1 expression within cancer nests in stage IIIA gastric cancer patients

  2016cites this paper
• Gastric adenocarcinoma microRNA profiles in fixed tissue and in plasma reveal cancer-associated and Epstein-Barr virus-related expression patterns

  2016cites this paper
• Gastric cancer and the epoch of immunotherapy approaches.

  2015cites this paper
• Bone marrow mesenchymal stem cells suppressing activation of allogeneic cytokine‐induced killer/natural killer cells either by direct or indirect interaction

  2015cites this paper
• Strategies and Advancements in Harnessing the Immune System for Gastric Cancer Immunotherapy

  2015cites this paper
• A Positive Role of Cytokine-Induced Killer Cell Therapy on Gastric Cancer Therapy in a Chinese Population: A Systematic Meta-Analysis

  2015cites this paper
• Tumor Immunotherapy of Esophageal and Gastric Cancers

  2015cites this paper
• Implication of different effector mechanisms by cord blood-derived and peripheral blood-derived cytokine-induced killer cells to kill precursor B acute lymphoblastic leukemia cell lines.

  2014cites this paper
• Effects of two different immunotherapies on triple negative breast cancer in animal model.

  2013cites this paper
• Moderating effects and maintenance of lung cancer cellular immune functions by CIK cell therapy.

  2013cites this paper
• Manipulating the immune response of Tasmanian Devils to target Devil Facial Tumour Disease

  2013cites this paper
• Increased tumor-infiltrating CD8+Foxp3+ T lymphocytes are associated with tumor progression in human gastric cancer

  2012cites this paper
• New adoptive immunotherapy strategies for solid tumours with CIK cells

  2012cites this paper
• T Cells in Gastric Cancer: Friends or Foes

  2012cites this paper
• Human interferon-alpha increases the cytotoxic effect of CD56(+) cord blood-derived cytokine-induced killer cells on human B-acute lymphoblastic leukemia cell lines.

  2012cites this paper
• Epstein-barr virus infected gastric adenocarcinoma expresses latent and lytic viral transcripts and has a distinct human gene expression profile

  2012cites this paper
• Novel Immunotherapeutic Strategies of Gastric Cancer Treatment

  2011cites this paper
• T Cells and Adoptive Immunotherapy: Recent Developments and Future Prospects in Gastrointestinal Oncology

  2011cites this paper
• This month in APR

  2010cites this paper
• RESEARCH ARTICLE Moderating Effects and Maintenance of Lung Cancer Cellular Immune Functions by CIK Cell Therapy

  year unknowncites this paper